These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17344303)

  • 61. Role of CD4 endocytosis in human immunodeficiency virus infection.
    Pelchen-Matthews A; Clapham P; Marsh M
    J Virol; 1995 Dec; 69(12):8164-8. PubMed ID: 7494343
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site.
    Klug YA; Ashkenazi A; Viard M; Porat Z; Blumenthal R; Shai Y
    Biochem J; 2014 Jul; 461(2):213-22. PubMed ID: 24766462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
    Chaiken I; Rashad AA
    Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515
    [No Abstract]   [Full Text] [Related]  

  • 64. HIV infection does not require endocytosis of its receptor, CD4.
    Maddon PJ; McDougal JS; Clapham PR; Dalgleish AG; Jamal S; Weiss RA; Axel R
    Cell; 1988 Sep; 54(6):865-74. PubMed ID: 3261635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Porphyromonas gingivalis-mediated Epithelial Cell Entry of HIV-1.
    Mantri CK; Chen C; Dong X; Goodwin JS; Xie H
    J Dent Res; 2014 Aug; 93(8):794-800. PubMed ID: 24874702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses.
    Hübner W; McNerney GP; Chen P; Dale BM; Gordon RE; Chuang FY; Li XD; Asmuth DM; Huser T; Chen BK
    Science; 2009 Mar; 323(5922):1743-7. PubMed ID: 19325119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD4 down-modulating compounds with potent anti-HIV activity.
    Vermeire K; Schols D; Bell TW
    Curr Pharm Des; 2004; 10(15):1795-803. PubMed ID: 15180541
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The activity of matrix metalloproteinase-9 is part of the mechanism of cell-to-cell HIV-1 endocytosis in dendritic cells.
    Ruggiero E; Toschi E; Federico M
    Curr Drug Discov Technol; 2011 Jun; 8(2):112-8. PubMed ID: 21190541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Can HIV-1 entry sites be deduced by comparing bulk endocytosis to functional readouts for viral fusion?
    Marin M; Melikyan GB
    J Virol; 2015 Mar; 89(5):2985. PubMed ID: 25657214
    [No Abstract]   [Full Text] [Related]  

  • 70. Reply to "Can HIV-1 entry sites be deduced by comparing bulk endocytosis to functional readouts for viral fusion?".
    Herold N; Müller B; Kräusslich HG
    J Virol; 2015 Mar; 89(5):2986-7. PubMed ID: 25657215
    [No Abstract]   [Full Text] [Related]  

  • 71. HIV entry: a game of hide-and-fuse?
    Melikyan GB
    Curr Opin Virol; 2014 Feb; 4():1-7. PubMed ID: 24525288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of the effect of Sphingomyelinase on rubellavirus infectivity in two cell lines.
    Otsuki N; Sakata M; Mori Y; Okamoto K; Takeda M
    Bio Protoc; 2018 Sep; 8(17):e2992. PubMed ID: 34395791
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Implication of Sphingolipids in Viral Infections.
    Thomas S; Samuel SV; Hoch A; Syphurs C; Diray-Arce J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139132
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.
    Torres M; Parets S; Fernández-Díaz J; Beteta-Göbel R; Rodríguez-Lorca R; Román R; Lladó V; Rosselló CA; Fernández-García P; Escribá PV
    Membranes (Basel); 2021 Nov; 11(12):. PubMed ID: 34940418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Manifold Roles of Sphingolipids in Viral Infections.
    Avota E; Bodem J; Chithelen J; Mandasari P; Beyersdorf N; Schneider-Schaulies J
    Front Physiol; 2021; 12():715527. PubMed ID: 34658908
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sphingolipids: Effectors and Achilles Heals in Viral Infections?
    Schneider-Schaulies S; Schumacher F; Wigger D; Schöl M; Waghmare T; Schlegel J; Seibel J; Kleuser B
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ceramide synthase 2 deletion decreases the infectivity of HIV-1.
    Barklis E; Alfadhli A; Kyle JE; Bramer LM; Bloodsworth KJ; Barklis RL; Leier HC; Petty RM; Zelnik ID; Metz TO; Futerman AH; Tafesse FG
    J Biol Chem; 2021; 296():100340. PubMed ID: 33515546
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucosylceramide synthase maintains influenza virus entry and infection.
    Drews K; Calgi MP; Harrison WC; Drews CM; Costa-Pinheiro P; Shaw JJP; Jobe KA; Han JD; Fox TE; White JM; Kester M
    PLoS One; 2020; 15(2):e0228735. PubMed ID: 32032363
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A biophysical perspective on receptor-mediated virus entry with a focus on HIV.
    Llorente García I; Marsh M
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183158. PubMed ID: 31863725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Membrane Dynamics in Health and Disease: Impact on Cellular Signalling.
    Adhyapak P; Kapoor S
    J Membr Biol; 2019 Oct; 252(4-5):213-226. PubMed ID: 31435696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.